These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 4597182

  • 1. Absence of serum blocking activity in mice immunologically tolerant to soluble histocompatibility-2 antigens.
    Wright PW, Law LW, Appella E, Bernstein ID.
    Transplantation; 1974 May; 17(5):524-30. PubMed ID: 4597182
    [No Abstract] [Full Text] [Related]

  • 2. Soluble transplantation antigens. Further studies of their tolerogenic properties.
    Law LW, Appella E, Strober S, Wright PW, Fischetti T.
    Transplantation; 1974 Dec; 18(6):487-95. PubMed ID: 4612886
    [No Abstract] [Full Text] [Related]

  • 3. Tissue distribution of I region-associated antigens in the mouse.
    Hauptfeld V, Hauptfeld M, Klein J.
    J Immunol; 1974 Jul; 113(1):181-8. PubMed ID: 4598886
    [No Abstract] [Full Text] [Related]

  • 4. Specificity of heterologous antisera to components solubilized from rat thymocyte membranes.
    Eshhar Z.
    Eur J Immunol; 1973 Nov; 3(11):668-73. PubMed ID: 4589167
    [No Abstract] [Full Text] [Related]

  • 5. Cell-mediated reactivity and serum blocking activity in tolerant rats. Studies on ten rats operationally tolerant to skin allografts using several independent assays.
    Wright PW, Bernstein ID, Hamilton B, Gluckman JC, HELLSTROM KE.
    Transplantation; 1974 Jul; 18(1):46-55. PubMed ID: 4152086
    [No Abstract] [Full Text] [Related]

  • 6. Immunological enhancement of renal allografts.
    Stuart FP, McKearn TJ, Fitch FW.
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):53-8. PubMed ID: 4140597
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of a heterologous immune serum against bone marrow cells of the mouse].
    von Broen B.
    Acta Biol Med Ger; 1974 Dec; 32(6):681-90. PubMed ID: 4153702
    [No Abstract] [Full Text] [Related]

  • 8. Recognition of transplantation antigen in vitro: blocking of recognition structures by specific antibody.
    Ramseier H, Lindenmann J.
    Eur J Immunol; 1971 Nov; 1(5):348-51. PubMed ID: 4945638
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of the immune response toward allografts in vivo. I. Selective suppression of the development of cell-mediated immunity by soluble alloantigens.
    Bonavida B, Zighelboim J.
    Cell Immunol; 1974 Jul; 13(1):52-65. PubMed ID: 4451974
    [No Abstract] [Full Text] [Related]

  • 10. Reactivity of lymphoid cells from mice humorally tolerant to histocompatibility antigens.
    Law LW, Appella E, Cohen J, Dean JH.
    Nat New Biol; 1973 Dec 12; 246(154):174-6. PubMed ID: 4148456
    [No Abstract] [Full Text] [Related]

  • 11. Immunotherapy in leukemia. Experimental and clinical approaches.
    Mathé G.
    Ser Haematol; 1972 Dec 12; 5(5):66-86. PubMed ID: 4151467
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Use of cross-reacting microbial antigens reversal of tolerance acquired for mouse transplantation antigens].
    Ogurtsov RP.
    Biull Eksp Biol Med; 1976 Sep 12; 82(9):1104-6. PubMed ID: 791393
    [Abstract] [Full Text] [Related]

  • 14. Surface H-2 antigen concentration requirement of somatic hybrid cells for IgM-mediated cytotoxicity.
    Rubio N.
    Nature; 1974 May 31; 249(456):461-3. PubMed ID: 4134883
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of spontaneous allorosette formation by sera from tolerant rats.
    Gluckman JC, Bansal SC, Wright PW, Hellström KE.
    Transplantation; 1974 Jan 01; 17(1):97-110. PubMed ID: 4588159
    [No Abstract] [Full Text] [Related]

  • 16. Cellular immunity and blocking serum activity in chimeric mice.
    Hellström I, Hellström KE, Trentin JJ.
    Cell Immunol; 1973 Apr 01; 7(1):73-84. PubMed ID: 4144408
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of skin allograft rejection and cytotoxic antibody production in two lines of mice genetically selected for "high" and "low" antibody synthesis.
    Liacopoulos-Briot M, Bouthillier Y, Mouton D, Lambert F, Decreusefond C, Stiffel C, Biozzi G.
    Transplantation; 1972 Nov 01; 14(5):590-6. PubMed ID: 4563199
    [No Abstract] [Full Text] [Related]

  • 18. Failure to detect cytotoxic lymphoid cells or humoral blocking factors in mouse radiation chimaeras.
    Grant CK, Leuchars E, Alexander P.
    Transplantation; 1972 Dec 01; 14(6):722-7. PubMed ID: 4566270
    [No Abstract] [Full Text] [Related]

  • 19. The cellular basis of transplantation tolerance.
    Elkins WL.
    Transplant Proc; 1973 Mar 01; 5(1):685-9. PubMed ID: 4144461
    [No Abstract] [Full Text] [Related]

  • 20. Antilymphocytic antibodies and marrow transplantation. V. Suppression of secondary disease by host-versus-theta-graft reaction.
    Thierfelder S, Rodt H.
    Transplantation; 1977 Jan 01; 23(1):87-92. PubMed ID: 319574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.